Biomarkers

Aepodia uses its know-how and expertise on a large number of Biomarkers and pharmacodynamic measurements to optimize the design and objectives of your early clinical development plan. This facilitates and optimizes the decision-making process for the positioning of your compound.

Aepodia has experience with the following biomarkers:

  • Neuropeptides
  • Biological markers
  • Vision tests
  • Caloric and metabolic tests
  • Cerebrospinal Fluid collection
  • Pharmaco-electroencephalograms
  • Sleep monitoring
  • Cognitive tests
  • Provocative tests
  • PET scans
  • Pain models
  • Spirometry
  • Urodynamics
  • Echography (cardiac, bladder, hepatic, pelvic, etc...)
  • Etc.